Organophosphorus compound effects on neurotrophin receptors and intracellular signaling

Melinda Pomeroy-Black1, Marion Ehrich

  • 1Department of Biology, LaGrange College, 601 Broad Street, LaGrange, GA 30240, USA. mblack@lagrange.edu

Insights

Neuropathic organophosphorus (OP) compounds disrupt neurotrophin signaling and cell survival pathways in neuroblastoma cells, unlike non-neuropathic OPs. This study reveals molecular mechanisms behind neuronal responses to OP exposure.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Organophosphorus (OP) compounds can cause neuropathy, affecting neuronal function.
  • Neuropathic OPs induce apoptosis and decrease neurite outgrowth in neuroblastoma cells.
  • OPs may interfere with neurotrophin-receptor binding and intracellular signaling.

Purpose of the Study:

  • To investigate how sub-lethal concentrations of neuropathic OP compounds affect neurotrophin-receptor binding and intracellular signaling pathways.
  • To compare the effects of a neuropathic OP (PSP) with a non-neuropathic OP (paraoxon) on SH-SY5Y neuroblastoma cells.
  • To elucidate the molecular mechanisms underlying neuronal responses to OP exposure.

Main Methods:

  • SH-SY5Y neuroblastoma cells were exposed to varying concentrations of PSP (neuropathic OP) and paraoxon (non-neuropathic OP).
  • Cells were also treated with nerve growth factor (NGF) alongside PSP.
  • Western blotting was used to analyze the phosphorylation status of neurotrophin receptors (pp75, pTrkA) and key signaling proteins (MEK1/2, Akt).

Main Results:

  • PSP exposure, especially at low doses or with NGF, increased phosphorylated pp75 receptor levels, suggesting a role in early cell death.
  • PSP exposure altered signaling pathways differently than paraoxon, with paraoxon activating MEK1/2, while PSP did not.
  • Both OP compounds activated Akt in the PI-3K cell-survival pathway, but paraoxon increased MAPK pathway activity, which PSP exposure prevented.

Conclusions:

  • Neuropathic OP compounds interfere with neurotrophin receptor signaling and inhibit MAPK pathway activation, crucial for neurite outgrowth and cell survival.
  • Non-neuropathic OP compounds activate the MAPK pathway, indicating differential molecular mechanisms between neuropathic and non-neuropathic OPs.
  • These findings reveal key molecular pathways involved in neuronal responses to neuropathic OP-induced toxicity.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...